[ #EHA2024 ] 'The good physician treats the disease. The great physician treats the family who has the disease'. Pr Professor Sam salek on the need to assess carers' quality of life of #bloodcancer patients & the development of the Family-reported outcomes measure #FROM16 EHA Patient Advocacy Committee

We are proud to have had you as our Chair Mandy Lauw! Thank you so much🙏🏼 for all your hard work advocating for the role of #YoungEHA 🌱 in European Hematology Association and #earlycareer professionals in #hematology , and look forward to continue your great work with our new Chair Nuno Borges !

Special welcome to YoungEHA!!! We need you in all European Hematology Association SWGs, and there are 24!! Choose yours!! #hematology #networking #mentoring #EHA2024

Glofitamab monotherapy as salvage therapy in heavily pretreated mantle cell #lymphoma

With Ana Marín Niebla as chair-Women In Lymphoma - [email protected] of the session! 💪 GELTAMO

#EHA2024

Realizing AI's potential in cardiology requires rigorous evaluation, appropriate infrastructure, regulatory oversight, ethics and equity analyses, and viable business cases for deployment. bit.ly/3VnoaGu

#JACC #AI #ArtificialIntelligence #HealthEquity Sneha Shah Jain, MD, MBA

And that's a wrap for #EHA2024 in beautiful Madrid! Honoured to have shared the SWG session with Müller-Tidow Lab José Javier Fuster, and thank you Raul Cordoba, MD, PhD #EHA2024 for the invitation! It’s always great to come back home to share my science

It's always hard to say ¡adiós! But our hearts are FULL after such an amazing congress #EHA2024 . Always great to see the vibrant #YoungEHA community in action! We look forward to bigger and brighter things in our future 🤩 See you in Milan! 🇮🇹

That's a wrap on #EHA2024 ! We would like to thank our delegates, faculty, and partners for joining us in Madrid for 3.5 days of learning and connection. We look forward to seeing you all again in Milan, Italy from June 12-15 for #EHA2025 .
Save the date: eha.fyi/ViewEHA2025

CONGRESS #EHA2024 | Pier Luigi Zinzani Università di Bologna reports outcomes from the VALENTINE-PTCL01 study of valemetostat 200 mg/day in pts with R/R PTCL. Primary endpoint; overall ORR was 44%; ORR for pts with 1, 2, and ≥ 3 prior LOT were 52.8%, 46.7%, and 35.8%, respectively. ORR trended

Congratulations again to all our #EHAGrants winners here at #EHA2024 !

Reunión de Presidentes de Sociedades Latinoamericanas con el Presidente de la European Hematology Association (Dr. Antonio Almeida) y miembros de la Comisión Directiva,en el Congreso Europeo de Hematología realizado en Madrid,España.

#networking
#EHA2024
#hematology
#hematología

Proud to share at #EHA2024 our GELTAMO RWE with tafa-lena in R/R DLBCL non-ASCT eligible
- Optimal cases: 1st-2nd relapses
- Relative-dose intensity matters
- Low impact age/CIRS
- 42% durable CRs
- Not for terminal palliative care

YouTube J&J Innovative Medicine España #IMPERDIBLESdeEHA #EHA2024 | #Leucemia Linfocítica Crónica #LLC /SLL recidivante o refractaria.

👉Estudio en fase 1 del degradador de la Tirosina Quinasa de Bruton #BTK BGB- 16673

👨‍⚕️Miguel Argüello Sant Pau - Campus Salut Barcelona
#SEHHContigo #SEHHematologia J&J Innovative Medicine España

CONGRESS | #EHA2024
William Wierda Bill Wierda, MD, PhD MD Anderson Cancer Center presents exploratory analyses from TRANSEND CLL 004 trial in heavily pre-treated patients with R/R #CLL / #SLL (median 5 prior lines of therapy).
▪️ Lower baseline disease burden was associated with achievement of

#EHA2024 has come to its end. The biggest European Hematology Association congress ever. I hope you have enjoyed as much as I did. Madrid 🇪🇸 will be remembered as one the best cities to host the congress. Safe flights ✈️ back home to all delegates! See you all in Milan 🇮🇹 at #EHA2025 #hematology

Por fin me encuentro con mi querida Lidiane Andino Neves en #EHA2024 . ¡¡El #networking con #LatAm continúa!! @sehh_es + Sociedad Paraguaya de Hematología y M.T. #Hematología #Hematología EnEspañol

Great talk about ctDNA in DLBCL by Stefan Alig at #EHA2024 🧬

International Members Committee of ASH meeting at #EHA2024 . Proud to be part of this innspiring group!

We've just kicked off our last day at #EHA2024 with a lovely interview w/ Natacha Bolaños of the Lymphoma Coalition (@knowyournodes)!😁

The footage will be live on our site soon!🎥

👉 vjhemonc.com/event/eha-2024/ 👈

#LYMsm #Lymphoma #HemOnc European Hematology Association

#EHA2024 Long term cause specific mortality in a cohort of 1,435 #Hodgkin #lymphoma treated at the national adult public cancer program in Chile 🇨🇱 over a 30 year period #lymsm . Age matters #geriheme